Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
US8058467 | BAUSCH AND LOMB | Prostaglandin derivatives |
Jan, 2025
(9 months from now) | |
US7910767 | BAUSCH AND LOMB | Prostaglandin derivatives |
Jan, 2025
(9 months from now) | |
US7273946 | BAUSCH AND LOMB | Prostaglandin derivatives |
Oct, 2025
(1 year, 6 months from now) | |
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US7629345 | BAUSCH AND LOMB | Prostaglandin derivatives |
Jan, 2025
(9 months from now) |
Market Authorisation Date: 02 November, 2017
Treatment: Reduction of intraocular pressure (iop) in patients with open-angle glaucoma or ocular hypertension
Dosage: SOLUTION/DROPS;OPHTHALMIC